High-sensitivity troponin T as a marker to predict cardiotoxicity in breast cancer patients with adjuvant trastuzumab therapy

The humanized monoclonal antibody trastuzumab has been in routine use for chemotherapy for human epidermal growth factor receptor II (HER2)-positive breast cancer. A major adverse effect of trastuzumab is cardiotoxicity. Well-established biomarkers or echocardiographic parameters to predict trastuzu...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Katsurada, Kenichi, Ichida, Masaru, Sakuragi, Masako, Takehara, Megumi, Hozumi, Yasuo, Kario, Kazuomi
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Springer International Publishing 2014
Gaiak:
Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4216824/
https://ncbi.nlm.nih.gov/pubmed/25392790
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2193-1801-3-620
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak